Scandion Oncology

About:

Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms.

Website: https://scandiononcology.com

Twitter/X: Scandion

Top Investors: EASME - EU Executive Agency for SMEs, Eurostars, Innovation Fund Denmark

Description:

Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms. Improving the outcome and quality of life for cancer patients is their mission. Drug resistance is one of the most significant challenges for successful medical treatment in oncology. Right now, half of all cancer patients fail chemotherapy. Although many cancer patients initially benefit from chemotherapy, a large proportion develop resistance to chemotherapy drugs. Few of these patients survive.